Latest news with #Niraj
South Wales Argus
3 days ago
- Health
- South Wales Argus
Mounjaro and Ozempic warning for holiday travel insurance
The last year has seen a huge increase in the number of people taking GLP-1 receptor agonists, including semaglutide (Wegovy and Ozempic), tirzepatide (Mounjaro) and liraglutide (Saxenda). Others may be taking tablets such as Orlistat or Alli. Travel insurance providers are warning that the growing number of Brits turning to these breakthrough drugs for weight management could lose their cover and face huge medical bills abroad if they don't declare their usage when arranging travel insurance. Review your ICB's local policy about treating patients with tirzepatide (Mounjaro) for weight management in a primary care setting and visit: — We are Primary Care (@PrimaryCareNHS) June 12, 2025 Many don't want to admit they are taking the weight-loss drugs, or think that if they buy it privately online, it doesn't need to be declared. Niraj Mamtora, director at Forum Insurance, says: 'Weight-loss medications like Ozempic are transforming lives across the UK, but too many travellers don't realise the insurance implications. If you're using these drugs, you must declare both the medication and the condition it's prescribed for. 'Failure to do so is not a minor oversight - it's a serious breach of your travel insurance contract. If you need medical help overseas and haven't declared your medication, your claim can be refused and your policy cancelled. The financial consequences can be severe.' What happens if you don't disclose weight-loss jabs on your travel insurance? 'Non-disclosure is a gamble that's simply not worth taking," says Niraj. "If you don't declare your medication or the underlying condition, your insurer is within their rights to refuse any claim, even if it seems unrelated. 'Many travellers only discover too late that their travel insurance claims are rejected, leaving them without support and facing potentially huge bills. Do I Need Travel Insurance? "With the average medical claim abroad now exceeding £1,700, and costs rising significantly with age, being properly covered is more important than ever.' 'Skinny Jab' weight loss medication is surging According to The Pharmacist website 1.5 million UK citizens used weight-loss jabs in March 2025, and the number is believed to be growing each month. 'Recent NHS data shows that between March 2024 and February 2025, more than 83,000 unique patients in England were dispensed Ozempic, while over 344,000 people received a prescription for weight-loss medications overall in the past year," says Niraj. 'With new drugs entering the market and millions more eligible for these treatments, the number of Brits travelling with prescription weight-loss medication is set to rise further.' Recommended reading: What to do if you are travelling abroad while taking weight-loss medication Declare all pre-existing medical conditions and any medications, including Ozempic, Wegovy, and Mounjaro, when purchasing travel insurance. If you are taking medication without a prescription or for off-label use, you must disclose this, as it can affect your travel cover. Carry a copy of your prescription or a doctor's letter when travelling with medication, and check the rules of your destination country regarding bringing in prescription drugs. Remember that insurance claims related to undeclared conditions or medications can be refused, even if the issue seems unrelated.
Glasgow Times
4 days ago
- Health
- Glasgow Times
Mounjaro and Ozempic warning for holiday travel insurance
The last year has seen a huge increase in the number of people taking GLP-1 receptor agonists, including semaglutide (Wegovy and Ozempic), tirzepatide (Mounjaro) and liraglutide (Saxenda). Others may be taking tablets such as Orlistat or Alli. Travel insurance providers are warning that the growing number of Brits turning to these breakthrough drugs for weight management could lose their cover and face huge medical bills abroad if they don't declare their usage when arranging travel insurance. Review your ICB's local policy about treating patients with tirzepatide (Mounjaro) for weight management in a primary care setting and visit: — We are Primary Care (@PrimaryCareNHS) June 12, 2025 Many don't want to admit they are taking the weight-loss drugs, or think that if they buy it privately online, it doesn't need to be declared. Niraj Mamtora, director at Forum Insurance, says: 'Weight-loss medications like Ozempic are transforming lives across the UK, but too many travellers don't realise the insurance implications. If you're using these drugs, you must declare both the medication and the condition it's prescribed for. 'Failure to do so is not a minor oversight - it's a serious breach of your travel insurance contract. If you need medical help overseas and haven't declared your medication, your claim can be refused and your policy cancelled. The financial consequences can be severe.' What happens if you don't disclose weight-loss jabs on your travel insurance? 'Non-disclosure is a gamble that's simply not worth taking," says Niraj. "If you don't declare your medication or the underlying condition, your insurer is within their rights to refuse any claim, even if it seems unrelated. 'Many travellers only discover too late that their travel insurance claims are rejected, leaving them without support and facing potentially huge bills. Do I Need Travel Insurance? "With the average medical claim abroad now exceeding £1,700, and costs rising significantly with age, being properly covered is more important than ever.' 'Skinny Jab' weight loss medication is surging According to The Pharmacist website 1.5 million UK citizens used weight-loss jabs in March 2025, and the number is believed to be growing each month. 'Recent NHS data shows that between March 2024 and February 2025, more than 83,000 unique patients in England were dispensed Ozempic, while over 344,000 people received a prescription for weight-loss medications overall in the past year," says Niraj. 'With new drugs entering the market and millions more eligible for these treatments, the number of Brits travelling with prescription weight-loss medication is set to rise further.' Recommended reading: What to do if you are travelling abroad while taking weight-loss medication Declare all pre-existing medical conditions and any medications, including Ozempic, Wegovy, and Mounjaro, when purchasing travel insurance. If you are taking medication without a prescription or for off-label use, you must disclose this, as it can affect your travel cover. Carry a copy of your prescription or a doctor's letter when travelling with medication, and check the rules of your destination country regarding bringing in prescription drugs. Remember that insurance claims related to undeclared conditions or medications can be refused, even if the issue seems unrelated.
The Herald Scotland
4 days ago
- Health
- The Herald Scotland
Mounjaro and Ozempic warning for holiday travel insurance
Travel insurance providers are warning that the growing number of Brits turning to these breakthrough drugs for weight management could lose their cover and face huge medical bills abroad if they don't declare their usage when arranging travel insurance. Review your ICB's local policy about treating patients with tirzepatide (Mounjaro) for weight management in a primary care setting and visit: — We are Primary Care (@PrimaryCareNHS) June 12, 2025 Many don't want to admit they are taking the weight-loss drugs, or think that if they buy it privately online, it doesn't need to be declared. Niraj Mamtora, director at Forum Insurance, says: 'Weight-loss medications like Ozempic are transforming lives across the UK, but too many travellers don't realise the insurance implications. If you're using these drugs, you must declare both the medication and the condition it's prescribed for. 'Failure to do so is not a minor oversight - it's a serious breach of your travel insurance contract. If you need medical help overseas and haven't declared your medication, your claim can be refused and your policy cancelled. The financial consequences can be severe.' What happens if you don't disclose weight-loss jabs on your travel insurance? 'Non-disclosure is a gamble that's simply not worth taking," says Niraj. "If you don't declare your medication or the underlying condition, your insurer is within their rights to refuse any claim, even if it seems unrelated. 'Many travellers only discover too late that their travel insurance claims are rejected, leaving them without support and facing potentially huge bills. Do I Need Travel Insurance? "With the average medical claim abroad now exceeding £1,700, and costs rising significantly with age, being properly covered is more important than ever.' 'Skinny Jab' weight loss medication is surging According to The Pharmacist website 1.5 million UK citizens used weight-loss jabs in March 2025, and the number is believed to be growing each month. 'Recent NHS data shows that between March 2024 and February 2025, more than 83,000 unique patients in England were dispensed Ozempic, while over 344,000 people received a prescription for weight-loss medications overall in the past year," says Niraj. 'With new drugs entering the market and millions more eligible for these treatments, the number of Brits travelling with prescription weight-loss medication is set to rise further.' Recommended reading: What to do if you are travelling abroad while taking weight-loss medication Declare all pre-existing medical conditions and any medications, including Ozempic, Wegovy, and Mounjaro, when purchasing travel insurance. If you are taking medication without a prescription or for off-label use, you must disclose this, as it can affect your travel cover. Carry a copy of your prescription or a doctor's letter when travelling with medication, and check the rules of your destination country regarding bringing in prescription drugs. Remember that insurance claims related to undeclared conditions or medications can be refused, even if the issue seems unrelated.
Indian Express
13-06-2025
- Indian Express
2 days after Rajasthan man dies in accident on Delhi-Jaipur highway, Gurgaon police yet to make any arrests
Two days after a 24-year-old from Rajasthan lost his life in an accident on the NH-48 Delhi-Jaipur highway in Gurgaon, the police are yet to locate the driver of the unidentified vehicle that allegedly crashed into his vehicle. Sumit Meena and four friends, all from Rajasthan, were travelling from Alwar to Delhi in a Hyundai I-20 on Wednesday when their vehicle met with an accident near Mannat Hotel at Sidhravali at around 3.30 am. While Sumit, who was from Sukhal village in Sawai Madhopur, succumbed to his injuries while being taken to Civil Hospital at Sector 10, his friends, Niraj Saini, Ramprasad, Yuvraj, and Arman Khan, were injured. They are currently undergoing treatment at various hospitals. As per a complaint filed by Kamal Singh Meena, Sumit's father, at Bilaspur police station, the vehicle was driven by Niraj, 29, the son of Vinod Saini from Alwar, when it collided with an unidentified large vehicle. Kamal, in his complaint, alleged that Niraj was driving negligently and at high speed. 'I have three sons. My son Sumit was the middle child. On Tuesday, he had come to Alwar to meet his friends. The police have not shared any updates. I do not want to say more,' Kamal told The Indian Express on Friday. Based on the complaint and medical reports, the police have registered a case under sections 106 (causing death by negligence), 125(a) (rash or negligent act endangering human safety), and 281 (rash driving on a public way) of the Bharatiya Nyaya Sanhita. 'The investigation is ongoing. We are awaiting the postmortem report of the deceased and statements from the injured once they recover. Efforts are also underway to identify the unidentified vehicle involved in the accident,' Police Inspector Dilbag, Station House Officer, Bilaspur police station, said.
Scottish Sun
29-05-2025
- Health
- Scottish Sun
Major holiday warning to any Brits who take skinny jabs over ‘serious breach' that could cost you £1,000s
Scroll down for more details on weight-loss drugs HOL NO Major holiday warning to any Brits who take skinny jabs over 'serious breach' that could cost you £1,000s Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) UK TOURISTS have been warned about a potential travel insurance issue in the lead up to summer. Travel experts revealed that failure to list skinny jabs on the documentation could cost you thousands. Sign up for Scottish Sun newsletter Sign up 2 British holiday-makers have been warned not make a common error when applying for travel insurance (stock image) Credit: Alamy Any Brits holidaying abroad have been reminded to list their skinny jabs on official documents. Failure to do so could potentially jeopardise the validity of your travel insurance, reports Birmingham Live. Experts at Forum Insurance have detailed how not declaring usage of weight management drugs such as Ozempic could cause you problems on holiday. Niraj Mamtora, director at the company, explained that weight-loss drugs must be declared when taking out travel insurance, as it could be deemed as a breach of contract. 'Weight-loss medications are transforming lives across the UK, but too many travellers don't realise the insurance implications," he said. "If you're using these drugs, you must declare both the medication and the condition it's prescribed for. 'Failure to do so is not a minor oversight - it's a serious breach of your travel insurance contract." He broke down how this can impact your coverage when travelling abroad. "If you need medical help overseas and haven't declared your medication, your claim can be refused and your policy cancelled," Niraj explained. "The financial consequences can be severe.' I was sick of trying fad diets and not losing weight but now I've shed FIVE STONE without fat jabs or silly eating plans This means you could be faced with an insurer who is "within their rights" to refuse a claim. "Non-disclosure is a gamble that's simply not worth taking," the expert continued. "If you don't declare your medication or the underlying condition, your insurer is within their rights to refuse any claim, even if it seems unrelated. 'Many travellers only discover too late that their travel insurance claims are rejected, leaving them without support and facing potentially huge bills." He revealed that the average medical claim abroad now exceeds £1,700, with costs rising significantly with age. What are the other side effects of weight loss jabs? Like any medication, weight loss jabs can have side effects. Common side effects of injections such as Ozempic include: Nausea: This is the most commonly reported side effect, especially when first starting the medication. It often decreases over time as your body adjusts. Vomiting: Can occur, often in conjunction with nausea. Diarrhea: Some people experience gastrointestinal upset. Constipation: Some individuals may also experience constipation. Stomach pain or discomfort: Some people may experience abdominal pain or discomfort. Reduced appetite: This is often a desired effect for people using Ozempic for weight loss. Indigestion: Can cause a feeling of bloating or discomfort after eating. Serious side effects can also include: Pancreatitis: In rare cases, Ozempic may increase the risk of inflammation of the pancreas, known as pancreatitis, which can cause severe stomach pain, nausea, and vomiting. Kidney problems: There have been reports of kidney issues, including kidney failure, though this is uncommon. Thyroid tumors: There's a potential increased risk of thyroid cancer, although this risk is based on animal studies. It is not confirmed in humans, but people with a history of thyroid cancer should avoid Ozempic. Vision problems: Rapid changes in blood sugar levels may affect vision, and some people have reported blurry vision when taking Ozempic. Hypoglycemia (low blood sugar): Especially if used with other medications like sulfonylureas or insulin. According to the firm, there appears to be a "growing trend" in people looking to use Ozempic, or other types of weight-loss drug. Niraj cited NHS data between March 2024 and February 2025, which showed that more than 83,000 "unique patients" in England were dispensed Ozempic. He also revealed over 344,000 individuals possessed a prescription for weight-loss medications in the past year. 'With new drugs entering the market and millions more eligible for these treatments, the number of Brits travelling with prescription weight-loss medication is set to rise further," the director said. If you're taking weight-loss drugs and planning a holiday abroad, make sure you have declared all pre-existing medical conditions and any other drugs to your travel insurance provider. If you are taking medication which has not been prescribed or for "off-label" usage, this must also be disclosed as it can affect your travel cover. "Carry a copy of your prescription or a doctor's letter when travelling with medication, and check the rules of your destination country regarding bringing in prescription drugs," the pro advised. "Remember that insurance claims related to undeclared conditions or medications can be refused, even if the issue seems unrelated."
